STOCK TITAN

Allergan Aesthetics Releases "Decoding the Future of Aesthetic Individuality" Exploring the Power of Self-Expression

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Positive)
Tags
Rhea-AI Summary
Allergan Aesthetics, an AbbVie company, released the 'Decoding the Future of Aesthetic Individuality' report, focusing on understanding the evolving consumer mix and their aesthetic needs. The report highlights the importance of individuality in aesthetics and the need for personalized approaches to consultation and treatment. It also emphasizes the role of social media in shaping beauty standards and the impact of individuality on defining beauty. The research includes insights from leading global experts and extensive research across consumer and business media, global social listening data, and market and industry reports from multiple geographies.
Positive
  • None.
Negative
  • None.

Understanding consumer preferences is pivotal for companies within the aesthetics industry, as it directly influences product development, marketing strategies and service offerings. The emphasis on individuality highlighted in the 'Decoding the Future of Aesthetic Individuality' report suggests a significant shift towards personalized aesthetics treatments, which could result in a diversification of product portfolios and potentially higher R&D expenses. However, this could also lead to increased customer satisfaction and loyalty and thus, potentially higher revenue streams for companies like Allergan Aesthetics.

Moreover, the report's findings on the importance of individualized consultations and the evolving definition of beauty could catalyze a trend in the aesthetics market, leading to a more inclusive range of treatments. This may also encourage aesthetic companies to leverage social media more strategically to connect with consumers and reflect the diverse definitions of beauty. The market could see an uptick in demand for personalized aesthetic solutions, which would be a significant factor for investors to consider when evaluating the growth potential of Allergan Aesthetics and its parent company, AbbVie.

The 'Decoding the Future of Aesthetic Individuality' report underscores the evolution of patient needs in the realm of medical aesthetics. From a clinical perspective, the push for individualized treatment plans is not just a trend but a necessary progression towards more ethical and patient-centric care. This evolution necessitates continuous professional development and advanced training for practitioners to meet the nuanced demands of patients, which may influence the operational costs and the quality of service delivery in the industry.

Furthermore, the report's insights could drive innovation in treatment modalities and technologies, as providers seek to offer bespoke solutions. The implications for stakeholders include the need to balance the investment in cutting-edge technologies with the assurance of a return on investment through patient satisfaction and loyalty. The long-term benefits of embracing individuality in aesthetics could lead to a more robust and differentiated market position for Allergan Aesthetics, potentially impacting its market share and competitive edge.

The findings of Allergan Aesthetics' report resonate with core principles of consumer psychology, particularly the increasing desire for personalized experiences and the impact of social media on perceptions of beauty. The data indicating that a significant majority of consumers value individualized approaches and perceive beauty diversely suggests a shift in consumer behavior. This shift has the potential to influence not only the aesthetics industry but also the broader consumer goods sector, as personalization becomes a key differentiator in consumer choice.

For businesses, understanding these psychological underpinnings is crucial for designing marketing campaigns and developing products that resonate with contemporary consumer values. The report's emphasis on individuality could lead to a reevaluation of marketing tactics, potentially affecting advertising spend and the strategic use of influencers. Companies that effectively integrate these insights into their business model could enjoy enhanced brand loyalty and a deeper connection with their consumer base.

-- New report incorporates in-depth interviews, industry research and social listening to understand the role of individuality in the world of aesthetics --

-- Report underpins ongoing commitment to aesthetics accessibility and inclusivity to achieve desired patient outcomes --

IRVINE, Calif., Jan. 31, 2024 /PRNewswire/ -- Today, Allergan Aesthetics, an AbbVie (NYSE: ABBV) company and a global leader in medical aesthetics treatments, released the "Decoding the Future of Aesthetic Individuality" report, which aims to deepen the understanding of the evolving consumer mix and their aesthetic needs. This report was commissioned to look at individuality through the lens of the aesthetics industry and how to support patients as they find and embrace their own personal definition of individuality when considering an aesthetic treatment. 

"When it comes to self-expression, consumers have different objectives; we all make our own choices on how to be our true selves. Delivering on those expectations requires consumers to understand what options are possible, and providers to assess and apply different techniques. This variety demands expertise from providers and that's why we continue to invest in training and research to offer treatments that reflect individual aesthetic goals," said Carrie Strom, Global President of Allergan Aesthetics and SVP, AbbVie. "The findings in 'Decoding the Future of Aesthetic Individuality' help us to understand and support the evolving needs of aesthetic consumers." 

This new report follows "The Future of Aesthetics Global Trends Report" launched by Allergan Aesthetics in 2022 that outlined 10 key trends set to shape the future of the aesthetics industry over the next 5 years. Individuality was featured as a key theme throughout the research.1 Individuality is a complex and multi-faceted concept, comprised of personal identity, inner motivations, needs, and the desire for self-expression and social connection.1 

"As a practicing dermatologist, I know firsthand that no two patients and their experiences are alike. I was happy to be able to contribute to this report and develop a resource that provides insight for aesthetics professionals to better communicate with patients and ultimately help them to achieve their own individual look," said U.S. dermatologist Dr. Mona Gohara. "A focus on individuality -- as a practitioner and as a consumer – is critical when considering the patient's perspective and delivering desired patient outcomes."

The Findings
The findings recognize the personal needs of each patient should be at the forefront of every interaction across the patient journey.1  Key research themes included: understanding individuality, the impact of social media and the opportunity for aesthetics professionals to work towards personalized approaches to consultation and treatment.

Research included in the consumer survey found that:

  • 90% of US respondents agree it is important to have an individualized approach to their aesthetics treatment consultation.
  • 81% of US respondents agree that they see a more varied version of what is considered beautiful in the media today.
  • 73% of US respondents agree that individuality drives the definition of beauty.

Research brought to you by leading global experts

Decoding the Future of Aesthetic Individuality is formulated from robust and extensive research across consumer and business media, global social listening data, and market and industry reports from multiple geographies, specifically Brazil, China, Japan, UK and USA. Findings were validated through 1:1 interviews with some of the world's leading aesthetics practitioners** as well as experts in psychology, beauty, marketing, consumer behaviour and futures.***

To receive the Decoding the Future of Aesthetic Individuality report and for more information, please contact your local Allergan Aesthetics representative or download the report here.

Notes to Editors

About the Decoding the Future of Aesthetic Individuality report

The Decoding the Future of Aesthetic Individuality report was commissioned by Allergan Aesthetics, an AbbVie company, and developed by future think tank Wunderman Thompson Intelligence. It provides aesthetics practitioners and consumers with a deeper understanding of the concept of individuality and how the aesthetics industry can support patients in expressing their own.

Key opinion leaders who contributed to the report are:

Dr. Jonquille Chantrey, Aesthetic Surgeon, United Kingdom. Dr Mona Gohara, Dermatologist, United States. Dr Luiz Gustavo, Plastic Surgeon, Injectables Specialist, Brazil. Dr Kiyoko Kato, Surgeon and Cosmetologist, Japan. Dr Alex Box, Identity Designer and Beauty Futurist, United Kingdom. Rae Morris, Makeup Artist, Australia. Dr Marco Antonio Correa Varella, Experimental Psychologist, Brazil. Geraldine Wharry, Fashion Futurist, Advisor and Founder of the Trend Atelier, United Kingdom

About Allergan Aesthetics

At Allergan Aesthetics, an AbbVie company, we develop, manufacture, and market a portfolio of leading aesthetics brands and products. Our aesthetics portfolio includes facial injectables, body contouring, plastics, skin care, and more. Our goal is to consistently provide our customers with innovation, education, exceptional service, and a commitment to excellence, all with a personal touch. For more information, visit www.allerganaesthetics.com

About AbbVie

AbbVie's mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women's health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio.

About Wunderman Thompson Intelligence

Wunderman Thompson Intelligence is Wunderman Thompson's futurism, research and innovation unit. It charts emerging and future global trends, consumer change, and innovation patterns—translating these into insight for brands. It offers a suite of consultancy services, including bespoke research, presentations, co-branded reports and workshops. It is also active in innovation, partnering with brands to activate future trends within their framework and execute new products and concepts.

Footnotes:
** Dr. Jonquille Chantrey, Aesthetic Surgeon, United Kingdom. Dr Mona Gohara, Dermatologist, United States. Dr Luiz Gustavo, Plastic Surgeon, Injectables Specialist, Brazil. Dr Kiyoko Kato, Surgeon and Cosmetologist, Japan.
*** Dr Alex Box, Identity Designer and Beauty Futurist, United Kingdom. Rae Morris, Makeup Artist, Australia. Dr Marco Antonio Correa Varella, Experimental Psychologist, Brazil. Geraldine Wharry, Fashion Futurist, Advisor and Founder of the Trend Atelier, United Kingdom.

References

1 Allergan Aesthetics. "The Future of Aesthetics global trends report." May 2022. ALL-AGNA-220005

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/allergan-aesthetics-releases-decoding-the-future-of-aesthetic-individuality-exploring-the-power-of-self-expression-302048600.html

SOURCE AbbVie

FAQ

What is the title of the report released by Allergan Aesthetics?

The report is titled 'Decoding the Future of Aesthetic Individuality.'

What is the ticker symbol for Allergan Aesthetics' parent company?

The ticker symbol for Allergan Aesthetics' parent company is ABBV.

What percentage of US respondents agree on the importance of individualized approach to aesthetics treatment consultation?

90% of US respondents agree on the importance of individualized approach to aesthetics treatment consultation.

What was the key theme featured in the previous report launched by Allergan Aesthetics in 2022?

Individuality was featured as a key theme in the previous report launched by Allergan Aesthetics in 2022.

What kind of research was included in the 'Decoding the Future of Aesthetic Individuality' report?

The report includes robust and extensive research across consumer and business media, global social listening data, and market and industry reports from multiple geographies.

ABBVIE INC.

NYSE:ABBV

ABBV Rankings

ABBV Latest News

ABBV Stock Data

284.74B
1.76B
0.11%
71.92%
0.74%
Pharmaceutical Preparation Manufacturing
Manufacturing
Link
United States of America
NORTH CHICAGO

About ABBV

AbbVie Inc. is a pharmaceutical company headquartered in North Chicago, Illinois. It is ranked 6th on the list of largest biomedical companies by revenue. Their primary product is Humira (adalimumab) ($21 billion in 2022 revenues, 37% of total), administered via injection. It is approved to treat autoimmune diseases including rheumatoid arthritis, Crohns disease, plaque psoriasis, and ulcerative colitis.